Clover Health Investments, Corp. /De

Ownership Transactions Reported by 25 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+473K	41.9%	$2.26	+$1.07M
Sells	5	-655K	58.1%	$3.43	-$2.25M
Net	-3	-182K	-16.1%		-$1.18M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Vivek Garipalli	Director, 10%+ Owner	$605M	+$999K	+0.17%	Aug 7, 2025
Chamath Palihapitiya	FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner	$29.5M			Jul 7, 2021
Andrew Toy	Chief Executive Officer, Director	$26.3M			Nov 8, 2025
Greenoaks Capital Partners Llc	Other*, 10%+ Owner	$24.5M			Nov 22, 2021
Peter Kuipers	Chief Financial Officer	$21.5M			Oct 29, 2025
Jamie L. Reynoso	CEO, Medicare Advantage	$10M	-$309K	-2.99%	Nov 4, 2025
Conrad Wai	CEO, Counterpart Health	$8.99M	-$743K	-7.63%	Oct 31, 2025
Brady Priest	CEO of Home Care	$7.87M	-$276K	-3.39%	Oct 31, 2025
Scott J. Leffler	Chief Financial Officer	$4.76M			Jan 25, 2024
R. Aric Sharp	CEO of Value Based Care	$3.91M			Aug 9, 2024
Karen Soares	General Counsel & Secretary	$3.04M	-$200K	-6.17%	Nov 14, 2025
Clover Health Investments, Corp. /De	Chief Technology Officer	$3.03M			Oct 31, 2023
Joseph R. Martin	General Counsel	$2.66M			Jun 14, 2023
Chelsea Clinton	Director	$1.98M			Jan 6, 2025
Lee Shapiro	Director	$1.97M			Jan 6, 2025
Demetrios L. Kouzoukas	Director	$1.73M			Jan 6, 2025
William G. Robinson Jr	Director	$1.71M			Jan 6, 2025
Anna U. Loengard	Director	$1.34M	+$68.8K	+5.39%	Aug 13, 2025
Nathaniel S. Turner	Director	$1.26M			Jan 7, 2021
Carladenise Edwards	Director	$986K	-$722K	-42.3%	Mar 7, 2025
Prabhdeep Singh	Chief Growth Officer	$855K			Sep 16, 2022
Thomas L. Tran	Director	$331K			Jan 6, 2025
Joseph Wagner	Chief Financial Officer	$24.5K			Aug 9, 2021
Mark Herbers	Interim CFO				Aug 13, 2021
Terrence Ronan	Interim CFO				Jan 27, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.